AMI

Menu
  • Home
  • health
  • Life hacks
  • Office tips
  • Interesting

Guide To Epigallocatechin Gallate (EGCG)

Uses And Benefits 

Clinical trials are currently being conducted on epigallocatechin Gallate because of its potential as a treatment for a variety of diseases and conditions. It is an antioxidant. It has antiviral properties, as well as antifungal and antibacterial ones. After 12 weeks, obese individuals who drank green tea with up to 460 mg of epigallocatechin galate per day saw significant weight loss. Oxidative Stress plays a significant role in the development and progression of many health issues. Heart disease, fatty liver, cancers and premature aging are all examples. Epigallocatechin Gallate is known to have powerful antioxidant properties. It may therefore reduce oxidative stresses that can cause these conditions.

Testing is also underway for new anticancer therapies that combine this catechin with conventional chemotherapy. In animal experiments, mice treated with epigallocatechin galate and exposed to smoke for 12 weeks showed fewer cellular changes than those who did not receive treatment. This compound is also believed to help prevent the brain damage caused neurodegenerative disease. Alzheimer’s is one of them.

Next, review the side effects and potential risks.

Next Page
Share
Tweet
Email

Related Articles

Guide to Daily Eye Health & Safety
Have Regular Eye Exams Optometrists recommend that individuals schedule an …

Guide to Daily Eye Health & Safety

Anaphylactic shock can be caused by a variety of factors.
Exercise Behaviors The causes of anaphylactic reactions are not well …

Anaphylactic shock can be caused by a variety of factors.

How to prevent flare-ups of Crohn’s disease with diet
Eat Smaller Meals More Frequently Experts recommend that people with …

How to prevent flare-ups of Crohn’s disease with diet

Foods to Avoid on the Whole30 Diet
Added Sugar According to studies, added sugar can cause obesity, …

Foods to Avoid on the Whole30 Diet

Popular Posts

    AMI

    Copyright © 2025 AMI
    About Us | Eu Policy | Contact Us | Privacy Policy | Terms of Service

    Ad Blocker Detected

    Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

    Refresh